NCT01077817: Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352) |
|
|
| Completed | N/A | 684815 | NA | Alendronate, FOSAMAX®, Etidronate, DIDRONEL®, Ibandronate, BONIVA®, Risedronate, ACTONEL®, ATELVIA®, Raloxifene, EVISTA® | Organon and Co, World Health Information Science Consultants, LLC | Esophageal Cancer, Squamous Cell Carcinoma, Adenocarcinoma | 02/12 | 02/12 | | |
NCT02731040: Exome Sequencing for Atypical Femoral Fractures |
|
|
| Completed | N/A | 38 | NA | Bisphosphonate, Aledronate (Fosamax), Zoledronate (Zometa and Reclast), Risendronate (Actonel and Atelvia), Etidronate (Didronel), Ibandronate (Boniva) | Washington University School of Medicine | Atypical Femoral Fractures, Osteoporosis, Bisphosphonate Therapy | 03/18 | 03/18 | | |
